572 related articles for article (PubMed ID: 17851648)
1. Relationship between glycated haemoglobin levels and mean glucose levels over time.
Nathan DM; Turgeon H; Regan S
Diabetologia; 2007 Nov; 50(11):2239-44. PubMed ID: 17851648
[TBL] [Abstract][Full Text] [Related]
2. [Glycated haemoglobin may in future be reported as estimated mean blood glucose concentration--secondary publication].
Borg R; Nerup J; Nathan DM; Kuenen J; Zheng H; Schoenfeld D; Heine RJ;
Ugeskr Laeger; 2009 Nov; 171(45):3262-5. PubMed ID: 19916193
[TBL] [Abstract][Full Text] [Related]
3. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
Makris K; Spanou L; Rambaouni-Antoneli A; Koniari K; Drakopoulos I; Rizos D; Haliassos A
Diabet Med; 2008 Feb; 25(2):174-8. PubMed ID: 18290858
[TBL] [Abstract][Full Text] [Related]
4. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?
Kuenen JC; Borg R; Kuik DJ; Zheng H; Schoenfeld D; Diamant M; Nathan DM; Heine RJ;
Diabetes Care; 2011 Aug; 34(8):1843-7. PubMed ID: 21700921
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
Pickup JC; Freeman SC; Sutton AJ
BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
[TBL] [Abstract][Full Text] [Related]
6. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
[TBL] [Abstract][Full Text] [Related]
7. What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes?
Hillman N; Herranz L; Grande C; Vaquero PM; Pallardo LF
Diabet Med; 2004 May; 21(5):468-70. PubMed ID: 15089792
[TBL] [Abstract][Full Text] [Related]
8. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
9. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
Karl D; Zhou R; Vlajnic A; Riddle M
Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin Glycosylation Index is not related with blood glucose.
Merino-Torres JF; Fajardo-Montañana C; Ferrer-García JC; Piñón-Sellés F
J Diabetes Complications; 2003; 17(5):249-53. PubMed ID: 12954152
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA(1c) in insulin-treated diabetes (MITRE Study).
Cooke D; Hurel SJ; Casbard A; Steed L; Walker S; Meredith S; Nunn AJ; Manca A; Sculpher M; Barnard M; Kerr D; Weaver JU; Ahlquist J; Newman SP
Diabet Med; 2009 May; 26(5):540-7. PubMed ID: 19646195
[TBL] [Abstract][Full Text] [Related]
12. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis.
Brennan AL; Gyi KM; Wood DM; Hodson ME; Geddes DM; Baker EH
J Cyst Fibros; 2006 Jan; 5(1):27-31. PubMed ID: 16202666
[TBL] [Abstract][Full Text] [Related]
13. Seasonal fluctuations of glycated hemoglobin levels in Japanese diabetic patients.
Sakura H; Tanaka Y; Iwamoto Y
Diabetes Res Clin Pract; 2010 Apr; 88(1):65-70. PubMed ID: 20047769
[TBL] [Abstract][Full Text] [Related]
14. Point-of-care testing of HbA1c and blood glucose in a remote Aboriginal Australian community.
Martin DD; Shephard MD; Freeman H; Bulsara MK; Jones TW; Davis EA; Maguire GP
Med J Aust; 2005 May; 182(10):524-7. PubMed ID: 15896181
[TBL] [Abstract][Full Text] [Related]
15. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
[TBL] [Abstract][Full Text] [Related]
17. Is HbA(1c) affected by glycemic instability?
Derr R; Garrett E; Stacy GA; Saudek CD
Diabetes Care; 2003 Oct; 26(10):2728-33. PubMed ID: 14514571
[TBL] [Abstract][Full Text] [Related]
18. Haemoglobin A1c is not a surrogate for glucose and insulin measures for investigating the early life and childhood determinants of insulin resistance and Type 2 diabetes in healthy children. An analysis from the Avon Longitudinal Study of Parents and Children (ALSPAC).
Shultis WA; Leary SD; Ness AR; Scott J; Martin RM; Whincup PH; Smith GD;
Diabet Med; 2006 Dec; 23(12):1357-63. PubMed ID: 17116188
[TBL] [Abstract][Full Text] [Related]
19. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
[TBL] [Abstract][Full Text] [Related]
20. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
Pickup JC; Kidd J; Burmiston S; Yemane N
Diabetes Metab Res Rev; 2006; 22(3):232-7. PubMed ID: 16389648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
